These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 3549879

  • 1. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC, Kennedy NM, Gribbon D.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [Abstract] [Full Text] [Related]

  • 2. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [Abstract] [Full Text] [Related]

  • 3. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 4. Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
    Kissling W, Möller HJ, Walter K, Wittmann B, Krueger R, Trenk D.
    Pharmacopsychiatry; 1985 May; 18(3):240-5. PubMed ID: 4011672
    [Abstract] [Full Text] [Related]

  • 5. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
    McLaren S, Cookson JC, Silverstone T.
    Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
    [Abstract] [Full Text] [Related]

  • 6. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 Nov; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 7. Side effects during long-term treatment with depot antipsychotic medication.
    Cookson JC.
    Clin Neuropharmacol; 1991 Nov; 14 Suppl 2():S24-30; discussion S30-2. PubMed ID: 1751940
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W, Boisvert D, Bradwejn J.
    Psychopharmacol Bull; 1984 Nov; 20(1):108-9. PubMed ID: 6371871
    [No Abstract] [Full Text] [Related]

  • 9. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
    McKane JP, Robinson AD, Wiles DH, McCreadie RG, Stirling GS.
    Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
    [Abstract] [Full Text] [Related]

  • 10. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 11. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA, Aderounmu AF.
    J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
    [Abstract] [Full Text] [Related]

  • 12. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R, Kabesh Ia, Papezhova G.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982 May; 82(1):116-8. PubMed ID: 6121437
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
    Gelders YG.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-11. PubMed ID: 3559159
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK, Wong KE, Tay WK, Gill RC.
    Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
    [Abstract] [Full Text] [Related]

  • 15. [Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
    Ushakov IuV, Kravchenko NE, Kopeĭko GI, Kalugina LI, Mirzoian MG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Oct; 90(7):99-104. PubMed ID: 1979463
    [Abstract] [Full Text] [Related]

  • 16. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 Oct; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].
    Woggon B, Dick P, Fleischhauer HJ, Gmür M, Gruber G, Angst J, Heimann H.
    Int Pharmacopsychiatry; 1977 Oct; 12(4):193-209. PubMed ID: 22515
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
    Wiles DH, McCreadie RG, Whitehead A.
    Psychopharmacology (Berl); 1990 Oct; 101(2):274-81. PubMed ID: 2349370
    [Abstract] [Full Text] [Related]

  • 19. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA.
    Pharmatherapeutica; 1983 Oct; 3(5):289-93. PubMed ID: 6133287
    [Abstract] [Full Text] [Related]

  • 20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.